Zentiva Group, a.s., headquartered in the Czech Republic, is a prominent player in the pharmaceutical industry, specialising in generic and over-the-counter medicines. Founded in 1998, the company has established a strong presence across Europe, with significant operations in key markets such as Central and Eastern Europe. Zentiva is renowned for its commitment to quality and accessibility, offering a diverse portfolio of products that includes prescription medications, consumer health products, and biosimilars. The company’s focus on innovation and sustainability sets it apart in a competitive landscape, enabling it to meet the evolving needs of healthcare providers and patients alike. With a robust market position, Zentiva has achieved notable milestones, including strategic partnerships and expansions that enhance its reach and capabilities. As a trusted name in pharmaceuticals, Zentiva continues to contribute to the health and well-being of communities across its operational regions.
How does Zentiva Group, a.s.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zentiva Group, a.s.'s score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zentiva Group, a.s., headquartered in the Czech Republic (CZ), currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company has not outlined any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As a current subsidiary, Zentiva Group's climate initiatives and emissions data may be influenced by its corporate family structure, but no specific cascading data from a parent organization has been provided. This lack of detailed emissions reporting suggests that Zentiva Group may still be in the early stages of developing its climate strategy or reporting framework. In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction. Zentiva Group's future commitments and initiatives will be crucial in aligning with industry standards and addressing climate change effectively.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zentiva Group, a.s. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.